PM agreement consisting of one (1) base and four (4) option periods for qiagen qiacube HT instrument serial number 014349 and qiagen qiacube HT instrument serial number 8188
Ended Awarded Last action
- Contract number
- 75F40124F80150
- Awardee
-
Franklin Young International, Incorporated UEI EDQMKDZR8L13
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $14,077
Award facts
- Opportunity
-
- 75F40124Q000217 Solicitation number
- Contract value 16% obligated
- $87,843.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Laurel, MD, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $14,077 |
About this award
Franklin Young International, Incorporated, a Service-Disabled Veteran-Owned Small Business (SDVOSB) headquartered in Upland, California, was awarded a Delivery Order valued at $87,843.34 by the Food and Drug Administration (FDA) on June 13, 2024. The contract covers preventive maintenance services for two QIAGEN QIACube HT instruments (Serial Numbers 014349 and 8188) located at the FDA's facility in Laurel, Maryland. The agreement includes one base period and four option periods, with an ultimate completion date of June 16, 2025. This award was designated as a Total Small Business set-aside and is issued under the Multiple Award Schedule (MAS) contracting vehicle using firm fixed price terms.
Franklin Young International's selection reflects its established expertise in providing laboratory equipment, scientific products, and related services to federal agencies. The company maintains a substantial federal portfolio, including a $500 million Indefinite Delivery Contract with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense and specialized contracts with agencies including the National Institutes of Health, Department of Veterans Affairs, and Department of Agriculture. This FDA award supports critical diagnostic and research operations by ensuring the continued functionality and reliability of QIAGEN molecular testing equipment essential to the agency's laboratory operations.
Quick answers
Who was awarded contract 75F40124F80150?
75F40124F80150 was awarded to Franklin Young International, Incorporated by Food and Drug Administration (Department of Health and Human Services) on June 13, 2024.
How much is contract 75F40124F80150 worth?
The government has obligated $14,077 on 75F40124F80150. Its current value, with exercised options, is $87,843.
Is contract 75F40124F80150 an order under another contract?
Yes. 75F40124F80150 is a delivery order under GS07F0636W, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75F40124F80150 competed?
The extent of competition for 75F40124F80150 was full and open competition. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award